Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Mandala

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 11, 2024
Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatmentPiotr Rutkowski, Mario Mandala
Cancer|July 10, 2019
The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysisEliana Rulli, Lorenzo Legramandi, Lorenzo Salvati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Transforming growth factor-beta signaling and regulatory T cellsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Is there a right-sided shift for colorectal cancer in women compared with men?Gianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
The Lancet. Oncology|March 21, 2002
Mediastinal lymphoadenopathy in a patient with breast cancerGuiseppe Curigliano, Mario Mandala, Ida Minchella, et al.
Journal for Immunotherapy of Cancer|January 19, 2022
Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont <i>et al</i>Jeffrey Weber, Mario Mandala, Paolo Antonio Ascierto, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Growth Factors: Thrombopoietic Property of the Pineal Hormone MelatoninPAOLO Lissoni, MARIO Mandala, FAUSTO Rossini, et al.
Seminars in Cancer Biology|May 4, 2017
PI3K-AKT-mTOR inhibition in cancer immunotherapy, reduxJake S O'Donnell, Daniela Massi, Michele W L Teng, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
Catheter-related bloodstream infections, part II: specific pathogens and preventionGianluigi Ferretti, Mario Mandala, Serena Di Cosimo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 7, 2003
Catheter-related bloodstream infections, part I: pathogenesis, diagnosis, and managementGianluigi Ferretti, Mario Mandala, Serena Di Cosimo, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 11, 2024
Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatmentPiotr Rutkowski, Mario Mandala
Cancer|July 10, 2019
The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysisEliana Rulli, Lorenzo Legramandi, Lorenzo Salvati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Transforming growth factor-beta signaling and regulatory T cellsGianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Is there a right-sided shift for colorectal cancer in women compared with men?Gianluigi Ferretti, Alessandra Felici, Francesco Cognetti, et al.
The Lancet. Oncology|March 21, 2002
Mediastinal lymphoadenopathy in a patient with breast cancerGuiseppe Curigliano, Mario Mandala, Ida Minchella, et al.
Journal for Immunotherapy of Cancer|January 19, 2022
Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont <i>et al</i>Jeffrey Weber, Mario Mandala, Paolo Antonio Ascierto, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Growth Factors: Thrombopoietic Property of the Pineal Hormone MelatoninPAOLO Lissoni, MARIO Mandala, FAUSTO Rossini, et al.
Seminars in Cancer Biology|May 4, 2017
PI3K-AKT-mTOR inhibition in cancer immunotherapy, reduxJake S O'Donnell, Daniela Massi, Michele W L Teng, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
Catheter-related bloodstream infections, part II: specific pathogens and preventionGianluigi Ferretti, Mario Mandala, Serena Di Cosimo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 7, 2003
Catheter-related bloodstream infections, part I: pathogenesis, diagnosis, and managementGianluigi Ferretti, Mario Mandala, Serena Di Cosimo, et al.
Pageof 7